ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 941,64
0,00%
Dow Jones
44 882,13
0,38%
DAX
21 727,20
0,48%
Brent Oil
76,265
0,28%
Bitcoin
104 509,30
-0,22%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Perspective Therapeutics Inc (CATX)

  7. Perspective Therapeutics Inc (CATX) Actualités

CATX

Perspective Therapeutics (CATX)

Perspective Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:CATX
DateHeureSourceTitreSymboleSociété
24/01/202513h26Edgar (US Regulatory)Form 8-K - Current reportAMEX:CATXPerspective Therapeutics Inc
24/01/202513h00GlobeNewswire Inc.Perspective Therapeutics Continues to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Updated Interim Data Presented at the 2025 ASCO Gastrointestinal Cancers SymposiumAMEX:CATXPerspective Therapeutics Inc
22/01/202513h00GlobeNewswire Inc.Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET to be Presented at the ASCO Gastrointestinal Cancers Symposium on January 24, 2025AMEX:CATXPerspective Therapeutics Inc
13/01/202514h00GlobeNewswire Inc.Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 43rd Annual J.P. Morgan Healthcare ConferenceAMEX:CATXPerspective Therapeutics Inc
10/01/202513h00GlobeNewswire Inc.Perspective Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceAMEX:CATXPerspective Therapeutics Inc
07/01/202522h50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
07/01/202522h48Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:CATXPerspective Therapeutics Inc
06/01/202514h00GlobeNewswire Inc.Perspective Therapeutics Appoints Juan Graham, MBA as Chief Financial OfficerAMEX:CATXPerspective Therapeutics Inc
04/12/202423h17Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]AMEX:CATXPerspective Therapeutics Inc
27/11/202413h00GlobeNewswire Inc.Perspective Therapeutics to Participate in Upcoming Investor Conferences in DecemberAMEX:CATXPerspective Therapeutics Inc
21/11/202413h15GlobeNewswire Inc.Perspective Therapeutics to Pursue Dose Escalation of [212Pb]VMT-α-NET in its Ongoing Phase 1/2a Clinical Trial Based on Data Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical SymposiumAMEX:CATXPerspective Therapeutics Inc
15/11/202422h08GlobeNewswire Inc.Perspective Therapeutics to Discuss Data on [212Pb]VMT-α-NET Presented at the 2024 North American Neuroendocrine Tumor Society (NANETS) Multidisciplinary NET Medical Symposium on November 21, 2024AMEX:CATXPerspective Therapeutics Inc
15/11/202400h14Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsAMEX:CATXPerspective Therapeutics Inc
14/11/202422h05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]AMEX:CATXPerspective Therapeutics Inc
12/11/202422h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CATXPerspective Therapeutics Inc
12/11/202422h05GlobeNewswire Inc.Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 3Q 2024 ResultsAMEX:CATXPerspective Therapeutics Inc
31/10/202412h00GlobeNewswire Inc.Perspective Therapeutics to Provide Business Highlights and Report Third Quarter 2024 Financial ResultsAMEX:CATXPerspective Therapeutics Inc
29/10/202412h00GlobeNewswire Inc.Perspective Therapeutics to Participate in Upcoming Investor Conferences in NovemberAMEX:CATXPerspective Therapeutics Inc
23/10/202413h00GlobeNewswire Inc.Perspective Therapeutics Presents Updates at the 37th Annual Congress of the European Association of Nuclear MedicineAMEX:CATXPerspective Therapeutics Inc
16/10/202413h00GlobeNewswire Inc.Perspective Therapeutics Begins Shipping Investigational Products from State-of-the-Art Radiopharmaceutical Manufacturing Facility in Somerset, New JerseyAMEX:CATXPerspective Therapeutics Inc
11/10/202414h30GlobeNewswire Inc.Perspective Therapeutics to Advance Investigation of Potential First-In-Class Radiopharmaceutical Therapy [212Pb]VMT01 Based on Data Presented at the 21st International Congress of the Society for Melanoma ResearchAMEX:CATXPerspective Therapeutics Inc
10/10/202423h14GlobeNewswire Inc.Perspective Therapeutics to Present at the 21st International Congress of the Society for Melanoma ResearchAMEX:CATXPerspective Therapeutics Inc
07/10/202413h00GlobeNewswire Inc.Perspective Therapeutics to Participate at the Oppenheimer Targeted Radiopharmaceutical Therapies in Oncology Summit & JonesResearch Virtual Radiopharma DayAMEX:CATXPerspective Therapeutics Inc
30/09/202413h00GlobeNewswire Inc.Perspective Therapeutics to Present at the 37th Annual Congress of the European Association of Nuclear MedicineAMEX:CATXPerspective Therapeutics Inc
10/09/202413h00GlobeNewswire Inc.Perspective Therapeutics Presents at the World Molecular Imaging Congress 2024AMEX:CATXPerspective Therapeutics Inc
05/09/202413h00GlobeNewswire Inc.Perspective Therapeutics Granted Fast Track Designation for VMT01 for the Diagnosis and Treatment of MC1R-Positive MelanomaAMEX:CATXPerspective Therapeutics Inc
28/08/202413h00GlobeNewswire Inc.Perspective Therapeutics to Participate in Upcoming Investor Conferences in SeptemberAMEX:CATXPerspective Therapeutics Inc
13/08/202411h39IH Market NewsRumble Shares Up 7% in Premarket After 27% Q2 Revenue Surge; More on EarningsAMEX:CATXPerspective Therapeutics Inc
12/08/202422h05GlobeNewswire Inc.Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal 2Q 2024 ResultsAMEX:CATXPerspective Therapeutics Inc
12/08/202411h47IH Market NewsU.S. Futures Steady as Markets Await Key Inflation Data, Oil Prices ClimbAMEX:CATXPerspective Therapeutics Inc
 Showing the most relevant articles for your search:AMEX:CATX

Dernières Valeurs Consultées

NASDAQ
AMZN
Amazon.com
EU
RNO
Renault
NYSE
DIS
Walt Disney
EU
DG
Vinci
EU
CAP
Capgemini
EU
GLE
Societe Generale
FTSE
UKX
FTSE 100
COIN
BTCUSD
Bitcoin
EU
HO
Thales
COIN
ADAUSD
Cardano
NASDAQ
MSFT
Microsoft
EU
ORA
Orange
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces